Samsung Biologics Co.,Ltd. (KRX:207940)
1,778,000
+12,000 (0.68%)
At close: Feb 27, 2026
-0.99% (1Y)
| Market Cap | 82.31T |
| Revenue (ttm) | 4.56T |
| Net Income (ttm) | 1.78T |
| Shares Out | 46.29M |
| EPS (ttm) | 26,628.00 |
| PE Ratio | 73.80 |
| Forward PE | 47.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 97,725 |
| Average Volume | 54,855 |
| Open | 1,760,000 |
| Previous Close | 1,766,000 |
| Day's Range | 1,741,000 - 1,778,000 |
| 52-Week Range | 1,509,860 - 1,987,000 |
| Beta | 0.21 |
| RSI | 55.53 |
| Earnings Date | Apr 29, 2026 |